Date post: | 02-Apr-2015 |
Category: |
Documents |
Upload: | sammy-peardon |
View: | 216 times |
Download: | 1 times |
Analgesia / Nociception Index
Mathieu JEANNE, MD, PhD
Anesthesia & Intensive Care
Cic-It 807 Inserm
University Hospital
Lille, France
Conflict of interest
• Mathieu JEANNE is consultant for MetroDoloris®
State of the art
Current understanding of general anesthesia
• Cortical reactions– consciousness– hypnosis > EEG assessment of depth of
hypnosis (bispectral index, entropy, etc)
• Sub cortical reactions : autonomous nervous system
• eye• heart rate• blood pressure• sweat (> pain monitor)
• analgesia / nociception balance evaluation through ANS reactions assessment
State of art
State of artAutonomous nervous system
parasympathetic system
sympathetic system
• pupil contraction
• slowing of heart rate
• bronchial constriction
• digestive system
• pupil dilation
• lacrimation
• increased heart rate and blood pressure
• bronchial dilation
• sweating
Why use the ECG signal ?
• electrical signal easy to measure on the skin surface
• used for standard clinical monitoring• standard during anesthesia practice / ICU / neo
natalogy• non invasive• provides continuous monitoring and assessment
of ANS reactions to stress / nociception• still usable in case of :
– hypovolemia– shock (hypovolemic, septic, cardiogenic...)– hypothermia
State of art
Heart Rate VariabilityRespiratory sinus arrhythmia
• Each respiratory cycle is associated with a fall in paraS tone
• this leads to a brief increase of heart rate (shortening of RR intervals)
• that can be best seen on a bi-dimensionnal RR series as successive local minima (I)
State of art
Spectral Analysis using Fourier transform
• Fourier transform has been widely used for heart rate variability analysis
– spectral powers measured on the RR series result from various actions of the ANS
– ANS sympathetic and paraS tones can be measured in the low (LF) and high frequency (HF) fields
– Very Low Frequencies (VLF) are influenced by thermo regulation and the endocrine system
Bpm
Time
70
90
50
instantaneous heart rate
Fourier transform
Power spectrum
Quantification
LF HF
Frequency
VLF
State of art
0,04 Hz 0,15 Hz0,4 Hz
HR[bpm2]
f [Hz]VLF LF HF0,004 Hz
Very Low frequencies (0.004-0.04 Hz) express thermoregulatory and endocrine activities
Low frequencies (0.04-0.15 Hz) are related to sympathetic and paraS tone modulations, and baroreflex activity
High frequencies (0.15-0.40 Hz) express parasympathetic tone variations only, mainly in relation with respiratory sinus arrhythmia
Fourier Transform Power SpectrumState of art
Respiratory sinus arrhythmiaSpectral Analysis
Respiratory sinus arrhythmia plays a prominent role among the various influences exerted on the sinus node
Example of spectral analysis in a patient during general anesthesia : the high frequency content is mainly explained by the influence of ventilation on the RR series
Respiratory rate
Respiratory spectral peak
State of art
Why is Fourier transform not used routinely ?
• The increase of respiratory rate from 8 to 12 cpm leads to two respiratory spectral peaks during the 5 min transition in the analyzing window
• ANS assessment is not possible during that period
State of art
Main disavantages of the fourrier transform analysis
-Just applicable for stable signals-Needs 5 minutes of recording to be accurate
Pichot et al. J Appl Physiol 1999 ; 86:1081-91
Fast wavelet transform
Mallat S. Une exploration des signaux en ondelettes. Ed Ecole Polytechnique
R&D
Main advantages:
- applicable with unstable signals
- Provide a reliable countinuous assessment
Focused on the high frequencies range analysis of the HRV, the ANI technology objectively assess the parasympathetic
reflex loop
ANS
Sinus node
Stretch receptor
s
Limitation:
Apnea
Limitation: Sinusal rythm
only
Technology
Respiratory arrhythmia and respiratory pattern
ventilatory pattern
In the absence of nociception : respiration is the main influence of variability
In case of nociception or anxiety : respiratory influence is lost, replaced by LF components (sympathetic activation) not visible in the high frequency field
Respiratory arrhythmia can be visualized directly on the RR series
State of art
General anesthesiatwo components
• Loss of consciousness– Hypnotic agents (propofol, halogens, …)– Effect on superficial cortex and thalamo
cortical loops– measurable on the surface EEG (e.g. BISTM)
• Reactivity– sub cortex reactions– opioids dampen reactivity– measurable on ANS reactions
• HF measurements of HRV provide direct paraS evaluation
hypothesis / clinical research
From ECG to ANI
1
2
3
hypothesis / clinical research
1
hypothesis / clinical research
1
2
hypothesis / clinical research
1
2
3
hypothesis / clinical research
Instead of the former methodology, here are our main advantages:
• 1: Exclusion of all artefacts from the ECG signal
• 2: Normalization
• 3: Fast wavelet transform analysis
• 4: Graphical measurement
• 5: Simple index
Change in respiratory rate : graphic measure not altered
The change in respiratory rate does not lead to a change in graphical measurements.
Simulated RR series during an increase of respiratory rate
hypothesis / clinical research
• Adult patients scheduled for surgery
• Total intra venous anesthesia : propofol + opioid;
• propofol adapted in order to keep Bispectral index in the predefined range [40-60]
• ECG recordings and post hoc processing of RR series in order to obtain «noStim – earlyLight – lightAnalg» sequences
• primary objective : anticipate hemodynamic reactivity (defined as a 20% increase of HR or SBP)
Clinical settinghypothesis / clinical
research
Patients and anesthetic protocol
• 49 patients included– sufentanil : 19 patients (0.3 µg.kg-1 at induction and 0.1
µg.kg-1 in case of reactivity)
– alfentanil : 18 patients (30 µg.kg-1 at induction and 10 µg.kg-1 in case of reactivity)
– remifentanil : 12 patients (0.24 µg.kg-1.min-1 decreasing until reactivity)
• 30 patients do not present reactivity
• 19 patients present reactivity– total : 51 sequences of reactivity– 1 to 4 sequences per patient
hypothesis / clinical research
Results
• RR series in two distinct situations– adequate analgesia, long before reactivity– 5 min before hemodynamic reactivity
Hemodynamic and HRV results; Mann Whitney U test
adequate analgesia
reactivity p
HR 59 (60-68) 72 (69-81) < 0.001
SBP (mmHg) 98 (89-126) 130 (113-142) < 0.001
HFnu 0.64 (0.46-0.74) 0.42 (0.30-0.51) < 0.001
AUCmin (nu) 1.33 (0.97-1.66) 0.82 (0.65-0.96) < 0.001
AUCtot (nu) 8.48 (6.13-10.41) 5.69 (4.39-6.67) < 0.001
hypothesis / clinical research
Results (2)
Correlation between• AUCminnu and HFnu (r2=0,81)• AUCtotnu and HFnu (r2=0,88)• AUCtotnu and AUCminnu (r2=0,92)
Linear regressionAUCtotnu = 5,1 * AUCminnu + 1,2
0
.2
.4
.6
.8
1
1.2
1.4
1.6
1.8
2
2.2
AU
Cm
in(n
u)
0 .2 .4 .6 .8 1HF/(HF+LF)
hypothesis / clinical research
ANI
• p<0,0001 (Mann Whitney)
10
20
30
40
50
60
70
80
90
100
AN
I
adequAnalg insuffAnalg
**
Results (3) Analgesia Nociception Index
• The maximum possible surface of respiratory influence is 0.2*64=12.8
• AUCtot = T1 + T2 + T3 + T4
• AUCmin = min (T1, T2, T3, T4)
• The occupied part of that surface is AUCtotnu / 12.8
or ANI = 100 * [(5.1*AUCminnu + 1.2) / 12.8]
ANI = 100 * AUCtotnu / 12.8
hypothesis / clinical research
How to interpret ANI ?
• Recommended target range based on available clinical data :
• 50-70
Actual thresholds
- 48
se=76% sp=72%
- 30
se=100% > reactivity
- 82
se=100% > adequate Analg
0
50
100
70
1-spécificité
sensibilitéSensitivity
1-Specificity
surface = 0.80
hypothesis / clinical research
clinical setting
ANI : relative paraS measurement
Clinical trial
Laparoscopic cholecystectomy
Protocol
• Adult patients• Emergency laparoscopic cholecystectomy• ASA status I or II ; no known alteration of autonomous
nervous system
• TIVA propofol, remifentanil, myorelaxation• controlled ventilation Vt=8ml/kg – RR 12 c/min
• Bispectral index maintained in [40-60] range• remifentanil target lowered at 2 ng/ml after tracheal
intubation ; increase in case of hemodynamic reactivity (20% increase in HR or SBP)
• ANI measurements
Preliminary results
• n=9 patients included• Hemodynamic reactivity
is always preceded by an ANI decrease
Data presented as media (interquartile). * p<0.01 vs AprInd (after induction). + p<0.01 vs AprChir (after surgery)
Clinical trial:Tetanic stimulation at 2 remifentanil targets
during TIVA
NeurosurgeryPreliminary results
• Adults• ASA I or II ; no know ANS alteration
• TIVA propofol + remifentanil + myorelaxation• controlled ventilation Vt=8ml/kg – RR 12 c/min
• Bispectral index maintained in [30-50]• Remifentanil target at 3 ng/ml after tracheal intubation
• 3 stimuli before incision– TET1 : remifentanil Ce = 3 ng/ml (tetanic stimulation)– TET2 : remifentanil Ce = 6 ng/ml– head holder insertion : remifentanil Ce = 6 ng/ml
• ANI• Papillary dilation reflex (Neurolight, IDMED)
Results
• N=14 patients included
• Propofol Ce = 2.6 (2.5-3.0) µg/ml
• Heart rate (FC), blood pressure (PA) and BIS did not change during tetanos and head holder insertion (TAP)
• ANI
• decreased significantly after all 3 stimuli vs nostim
• less ANI decrease after TET2 vs TET1
• Pupilary dilation reflex decreased also after TET2 vs TET1
Results
- propofol target : 2,6 µg.ml-1 (2,5-3,0)
0
5
10
15
20
25
30
35
40
NoStim TET 1 TET 2 TAP0
5
10
15
20
25
30
35
40
NoStim TET 1 TET 2 TAP
RDP (%)
0
20
40
60
80
100
00:00 00:02 00:05 00:08 00:11 00:14 00:17temps (minute)
NoStim TET 1 TET 2 TAP
Example of ANI variation and HR during nociceptive stimuli
Case report
Mesenteric artery occlusionand general anesthesia
Mesenteric ischemia• Man, 43 year, no known disease• Comes to the casualty ward for acute abdominal pain
• abdominal CT scan : upper mesenteric artery occlusion
• first attempt at surgery– dissection of upper mesenteric artery– no bypass possible– conservative treatment (heparin)
• second look after 48h– small bowel necrosis over 10cm and sub ischemia over 1m– bowel resection– ilio-mesenteric bypass
Blind anesthesia• TIVA
– propofol (Schnider)– remifentanil (Minto)
• Tachycardia from the beginning (110 / min)– leading to fluid expansion 2000ml– increasing remi targets
• After 2h surgery– persistent tachycardia : 110 / min– BP 98/60 mmHg– total blood loss : 150 ml– remifentanil : target = 6 ng/ml– propofol : target = 3.5 µg/ml
Question : are analgesia and hypnosis adequate ?
EEG monitor + ANI monitor
• ANI– elevated index : 100– high para tone– > remi target is halved
from 6 to 3 ng/ml– no effect on HR or BP
during the next hour
• Bispectral index (Aspect A2000)– measure is within the [40-
60] range– >> propofol target is
maintained constant at 3.5 µg/ml
Future validation...
A.N.I.
• Test whether cardiovascular drugs modify ANI predictability of hemodynamic reactivity– beta bloquing drugs– catecholamines
• Limitations – no recording during apnea– sinus rhythm only
controlled ventilationInduction
Base Primea
apnea
intubation
0
10
20
30
40
50
60
70
80
90
100
0 100 200 300 400 500 600 700 800
Irregular tidal volume during induction
followed by apnoea
ANI non usablecontrolled
ventilation : ok
before induction
spontaneous Ventilation
Conclusion
• The surge of ANS monitoring devices is probably a promise of personalized anesthetic care in the coming years, esp. analgesia / nociception balance monitoring.
• These new monitoring devices underline the role of anesthesia as an ANS oriented discipline.